Sectra ABMIL:1SECT 76 5-Year Yield-on-Cost % is 0.47 as of Jun. 27, 2026, which is 49% below its 10-year median of 0.92. GuruFocus rates MIL:1SECT with a GF Score™ of 76/100 and a GF Value™ of €28.93 (Fairly Valued). Among 328 Medical Devices & Instruments companies, Sectra AB ranks worse than 87.5% on this metric.
Sectra AB's yield on cost for the quarter that ended in Apr. 2026 was 0.47.
The historical rank and industry rank for Sectra AB's 5-Year Yield-on-Cost % or its related term are showing as below:
MIL:1SECT'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.38 Med: 0.92 Max: 4.76
Current: 0.47
During the past 13 years, Sectra AB's highest Yield on Cost was 4.76. The lowest was 0.38. And the median was 0.92.
MIL:1SECT's 5-Year Yield-on-Cost % is ranked worse than 87.5% of 328
companies
in the Medical Devices & Instruments industry
Industry Median: 2.37
vs MIL:1SECT: 0.47
Sectra AB (MIL:1SECT) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Sectra AB 5-Year Yield-on-Cost % Related Terms
MIL:1SECT vs ABT, SYK, MDT: 5-Year Yield-on-Cost % Comparison
For the Medical Devices subindustry, Sectra AB's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sectra AB 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sectra AB's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Sectra AB's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Sectra AB is calculated as
Sectra AB (MIL:1SECT) has a 5-Year Yield-on-Cost % of 0.47 as of Jun. 27, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Sectra AB and its competitors. This is 49% below median its historical median of 0.92. Over the past decade, Sectra AB's 5-Year Yield-on-Cost % has ranged from 0.38 to 4.76. According to the industry distribution chart, Sectra AB ranks #287 out of 328 companies in the Medical Devices & Instruments industry, placing it in the top 87.5%.
Is Sectra AB's 5-Year Yield-on-Cost % too high?
Sectra AB's current 5-Year Yield-on-Cost % of 0.47 is 49% below median its 10-year median of 0.92. Over the past 10 years, this metric has ranged from a low of 0.38 to a high of 4.76. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.37. Sectra AB's value of 0.47 is 80.2% below this industry median. Based on the distribution chart, Sectra AB ranks #287 out of 328 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Sectra AB has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sectra AB's 5-Year Yield-on-Cost % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sectra AB ranks #287 out of 328 companies for 5-Year Yield-on-Cost %. This places Sectra AB in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.37. Sectra AB's value of 0.47 is 80.2% below this benchmark. Historically, Sectra AB's own 5-Year Yield-on-Cost % has ranged from 0.38 to 4.76 over the past decade. While the company's 10-year median is 0.92 vs. the industry median of 2.37, Sectra AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.37, based on 328 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sectra AB's current 5-Year Yield-on-Cost % of 0.47 is 80.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Sectra AB and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sectra AB's current 5-Year Yield-on-Cost % is 0.47, which is 49% below median its own 10-year median of 0.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sectra AB stock overvalued right now?
Based on GuruFocus' analysis, Sectra AB (MIL:1SECT) is currently considered Fairly Valued. The stock's GF Value™ is €28.93, compared to a current price of €27.38 — trading 5.4% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.47, which is 49% below median its 10-year median of 0.92 and 80.2% below the Medical Devices & Instruments industry median of 2.37. Sectra AB's overall GF Score™ is 76/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Sectra AB (MIL:1SECT), the current 5-Year Yield-on-Cost % is 0.47 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sectra AB (MIL:1SECT) Overvalued in 2026?
Based on GuruFocus' analysis, Sectra AB stock appears to be undervalued.
The current stock price of €27.38 is trading 5.4% below its estimated GF Value™ of €28.93.
GuruFocus considers Sectra AB to be Fairly Valued.
Key valuation signals for MIL:1SECT:
5-Year Yield-on-Cost %: 0.47 (49% below median its 10-year median of 0.92)
GF Value™: €28.93 vs. price of €27.38 (5.4% below fair value)
Industry Position: 80.2% below the Medical Devices & Instruments median (#287 of 328)
No single metric tells the full story. See the MIL:1SECT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sectra AB develops IT solutions and services for storing, viewing, and working with medical images. The operating business segments are Imaging IT Solutions, Secure Communications, Business Innovation, and Other Operations. It generates maximum revenue from the Imaging IT Solutions segment. The company also offers maintenance in the form of support, system monitoring, and consulting services related to integration, system design, data migration, and business development. Geographically, it derives a majority of its revenue from the United States, followed by Sweden, the United Kingdom, the Netherlands, the Rest of Europe, and the Rest of the world.
76GF Score
Get the complete analysis for MIL:1SECT
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1SECT has been successfully added to your 